Select Page

Biopharma backer VenBio soars past Fund III target to reach $394m final close

Biopharma backer VenBio soars past Fund III target to reach $394m final close


Biopharma development investor VenBio Partners has soared past its target for its third life sciences fundraise to close



Source link

About The Author

Leave a reply

Your email address will not be published. Required fields are marked *